3,4- dihydroxy- 5- (6- ((4- hydroxy- 3- methoxybenzyl)amino)- 9H- purin- 9- yl)tetrahydrofuran- 2- yl)methyl decanoate

01/01/2014 - "WS0701 effectively mitigates stress-induced PTSD-like behaviors in mice, partly via inhibition of neuronal apoptosis in the hippocampus."
01/01/2014 - "WS0701 administration significantly alleviated fear, anxious behaviors and memory deficits in the mouse model of PTSD. "
01/01/2014 - "Protective effects of the novel adenosine derivative WS0701 in a mouse model of posttraumatic stress disorder."
01/01/2014 - "The positive control drug paroxetine exerted similar effects on PTSD-like behaviors and hippocampal neuron apoptosis in the mouse model of PTSD, which were comparable to those caused by the high dose of WS0701. "
01/01/2014 - "To investigate the effects of the novel N6-substituted adenosine derivative {(2R,3S,4R,5R)-3,4-dihydroxy-5-[6-[(4-hydroxy-3-methoxybenzyl)amino]-9H-purin-9-yl]tetrahydrofuran-2-yl} methyl decanoate (WS0701) on stress-induced excessive fear, anxiety, and cognitive deficits in a mouse model of posttraumatic stress disorder (PTSD). "

10/01/2014 - "WS0701 did not protect mice against picrotoxin-induced seizures, but inhibited adenosine deaminase activity and increased adenosine levels in the frontal cortex and hypothalamus of mice. "

01/01/2014 - "WS0701 administration significantly alleviated fear, anxious behaviors and memory deficits in the mouse model of PTSD. "